ストックスクリーナーアプリを入手
489.98
0.69%
3.37
アフターアワーズ：
489.98
前日終値:
$486.61
開ける：
$487.14
24時間の取引高:
802.22K
Relative Volume:
0.97
時価総額：
$37.91B
収益：
$3.93B
当期純損益:
$894.97M
株価収益率:
45.28
EPS:
10.82
ネットキャッシュフロー:
$837.70M
1週間 パフォーマンス:
+3.95%
1か月 パフォーマンス:
+35.71%
6か月 パフォーマンス:
+13.09%
1年 パフォーマンス:
+0.60%
1日の値動き範囲:
$485.40
$495.56
1週間の範囲:
$465.00
$495.56
52週間の値動き範囲:
$356.14
$548.88
Idexx Laboratories Inc Stock (IDXX) Company Profile
名前
Idexx Laboratories Inc
セクター
電話
(207) 556-0300
住所
ONE IDEXX DRIVE, WESTBROOK, ME
IDXX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
489.98 | 37.91B | 3.93B | 894.97M | 837.70M | 10.82 |
|
TMO
Thermo Fisher Scientific Inc
|
410.78 | 158.51B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
194.82 | 140.78B | 23.82B | 3.77B | 4.90B | 5.15 |
|
A
Agilent Technologies Inc
|
108.70 | 31.23B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.29 | 26.31B | 15.41B | 1.37B | 2.11B | 7.50 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-02 | 開始されました | Leerink Partners | Outperform |
| 2024-07-25 | 開始されました | BTIG Research | Buy |
| 2024-01-30 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | 開始されました | Exane BNP Paribas | Outperform |
| 2023-12-04 | アップグレード | Cleveland Research | Neutral → Buy |
| 2023-08-02 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | ダウングレード | Stifel | Buy → Hold |
| 2022-07-21 | アップグレード | Goldman | Neutral → Buy |
| 2022-07-12 | 開始されました | Piper Sandler | Overweight |
| 2022-05-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-02-08 | 開始されました | Atlantic Equities | Overweight |
| 2021-11-18 | 開始されました | Morgan Stanley | Overweight |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-12 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-02-17 | 開始されました | Barclays | Overweight |
| 2019-09-09 | 開始されました | Goldman | Neutral |
| 2019-05-23 | 開始されました | Guggenheim | Buy |
| 2018-11-02 | 繰り返されました | BofA/Merrill | Buy |
| 2018-05-07 | 繰り返されました | Stifel | Buy |
| 2018-01-16 | 開始されました | Piper Jaffray | Overweight |
| 2017-08-23 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | アップグレード | CL King | Neutral → Buy |
| 2017-02-03 | ダウングレード | Feltl & Co. | Hold → Sell |
| 2016-09-29 | 再開されました | BofA/Merrill | Neutral |
| 2016-08-16 | 繰り返されました | Stifel | Buy |
| 2016-08-03 | アップグレード | Northcoast | Sell → Neutral |
| 2016-07-20 | 繰り返されました | Canaccord Genuity | Buy |
| 2016-04-19 | 繰り返されました | Canaccord Genuity | Buy |
| 2016-04-01 | 開始されました | CL King | Neutral |
| 2016-03-21 | 繰り返されました | Stifel | Buy |
| 2016-02-04 | 開始されました | Credit Suisse | Outperform |
| 2015-10-29 | 繰り返されました | Stifel | Buy |
| 2015-08-28 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | 繰り返されました | Stifel | Buy |
| 2015-07-23 | 繰り返されました | Canaccord Genuity | Buy |
すべてを表示
Idexx Laboratories Inc (IDXX) 最新ニュース
Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX) - Yahoo Finance
IDEXX Laboratories (IDXX) Target Price Raised by Morgan Stanley | IDXX Stock News - GuruFocus
BTIG Raises Price Target on IDEXX Laboratories to $545 From $530, Maintains Buy Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $558 From $548, Maintains Overweight Rating - marketscreener.com
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2025 Earnings Call Transcript - Insider Monkey
IDEXX Laboratories [NasdaqGS:IDXX] Raises 2025 Guidance and Reports Q1 Growth in Revenue and EPS - Yahoo Finance
Leerink Partners Adjusts IDEXX Laboratories Price Target to $515 From $500 - marketscreener.com
IDEXX Laboratories Announces First Quarter Results | IDXX Stock News - GuruFocus
IDEXX Laboratories (IDXX) Surpasses Q1 Expectations with Robust Earnings - GuruFocus
IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid ... - Yahoo Finance
IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid Market Challenges - GuruFocus
IDEXX Laboratories Reports Strong Q1 2025 Results - TipRanks
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) CEO Compensation Looks Acceptable To Us And Here's Why - simplywall.st
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Lab jumps after Q1 beat and guidance raise - MSN
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
Stifel Adjusts Price Target for Idexx Laboratories (IDXX) Following Q1 Results | IDXX Stock News - GuruFocus
IDEXX Laboratories (IDXX) Surges After Lifting 2025 Outlook on F - GuruFocus
IDEXX Laboratories stock jumps on Q1 beat (IDXX:NASDAQ) - Seeking Alpha
IDEXX Laboratories (IDXX) Reports Strong Start to 2025 with Reve - GuruFocus
IDEXX Laboratories Ups Profit Forecast Thanks To Pet Care Demand - Finimize
Earnings call transcript: IDEXX Labs Q1 2025 EPS beats forecast, stock surges - Investing.com
IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market - TradingView
IDEXX beats the Street on Q1 results, raises 2025 outlook - Mainebiz
Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist? - Yahoo Finance
IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics - marketscreener.com
IDEXX (IDXX) Reports Q1 Revenue Exceeding Expectations | IDXX St - GuruFocus
IDEXX Laboratories Q1 Earnings, Revenue Increase; 2025 Outlook Raised - marketscreener.com
Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates - Yahoo Finance
Idexx: Q1 Earnings Snapshot - MySA
IDEXX Laboratories Q1 2025 Earnings: EPS of $2.96 Beats Estimate - GuruFocus
IDEXX Laboratories Inc Q1 Profit Advances, Beats Estimates - Nasdaq
IDEXX LABS Earnings Results: $IDXX Reports Quarterly Earnings - Nasdaq
Earnings Flash (IDXX) IDEXX Laboratories Posts Q1 EPS $2.96, vs. FactSet Est of $2.85 - marketscreener.com
IDEXX Labs earnings beat by $0.05, revenue fell short of estimates - Investing.com South Africa
IDEXX Laboratories Announces First Quarter Results - TradingView
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss? - TradingView
Here's How Much $100 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today - Benzinga
Press Release Distribution & PR Platform - ACCESS Newswire
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term - Yahoo
Animal Health Diagnosis Market Is Booming So Rapidly with IDEXX Laboratories, Zoetis - openPR.com
Earnings Preview: What to Expect From IDEXX Laboratories' Report - MSN
Earnings Preview: What To Expect From IDEXX Laboratories' Report - Barchart.com
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$427 Based On Its Intrinsic Value? - simplywall.st
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
'The Nite Show with Danny Cashman' is Coming to an End - 94.9 HOM
A Look Into IDEXX Laboratories Inc's Price Over Earnings - Benzinga
Idexx Laboratories Inc (IDXX) 財務データ
収益
当期純利益
現金流量
EPS
1.10%
0.01%
大文字化:
|
ボリューム (24 時間):